First Indian mRNA vaccine gets nod for Phase 2/3 trials

Representative image. Credit: iStock Photo

India's first mRNA vaccine HGCO19 received DCGI nod for Phase II/III clinical trials on Tuesday. The Covid-19 vaccine has been developed by Gennova Biopharmaceuticals Ltd, a Pune-based biotechnology company in partnership with the Department of Biotechnology.

More to follow...